Advances into understanding metabolites as signaling molecules in cancer progression |
| |
Affiliation: | 1. Sahlgrenska Cancer Center, Department of Surgery, Institute of Clinical Sciences, University of Gothenburg, SE-405 30 Gothenburg, Sweden;2. Wallenberg Centre for Molecular and Translational Medicine, University of Gothenburg, SE-405 30 Gothenburg, Sweden;3. Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA;4. Perlmutter Cancer Center, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA |
| |
Abstract: | Recent years have seen a great expansion in our knowledge of the roles that metabolites play in cellular signaling. Structural data have provided crucial insights into mechanisms through which amino acids are sensed. New nutrient-coupled protein and RNA modifications have been identified and characterized. A growing list of functions has been ascribed to metabolic regulation of modifications such as acetylation, methylation, and glycosylation. A current challenge lies in developing an integrated understanding of the roles that metabolic signaling mechanisms play in physiology and disease, which will inform the design of strategies to target such mechanisms. In this brief article, we review recent advances in metabolic signaling through post-translational modification during cancer progression, to provide a framework for understanding signaling roles of metabolites in the context of cancer biology and illuminate areas for future investigation. |
| |
Keywords: | Metabolism Metabolic signaling Cancer |
本文献已被 ScienceDirect 等数据库收录! |
|